References:
[1] Hodiamont, Caspar J et al. (2022-08). “Clinical pharmacokinetics of gentamicin in various patient populations and consequences for optimal dosing for Gram-negative infections: An updated review”. en. In: Clin. Pharmacokinet. 61.8, pp. 1075–1094. ISSN: 0312-5963,1179-1926. DOI: 10.1007/s40262 - 022 - 01143 - 0. URL: http://dx.doi.org/10.1007/s40262-022-01143-0